Article
Host genetic influences on highly active antiretroviral therapy efficacy and AIDS-free survival.
Journal of acquired immune deficiency syndromes (1999) - 1 Jul 2008
Hendrickson Sher L, Jacobson Lisa P, Nelson George W, Phair John P, Lautenberger James, Johnson Randall C, Kingsley Lawrence, Margolick Joseph B, Detels Roger, Goedert James J, O'Brien Stephen J
Abstract excerpt
We studied the influence of AIDS restriction genes (ARGs) CCR5-Delta32, CCR2-64I, SDF1-3'A, IL10-5'A, CX3CR1-V249I, CX3CR1-T280M, and MDR1-C3435T and haplotypes of the CCR5 P1 promoter and RANTES variants -403A, In1.1C, 3'222C, and -28G among HIV-1 infected patients on highly active antiretroviral therapy (HAART) in the Multicenter AIDS Cohort Study (MACS) and the Multicenter Hemophilia Cohort Study (MHCS). Our...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
